BUSINESS

• Ivermectin COVID-19 Trial Needed Because Evidence Is Lacking, Kowa Says as It Aims for PIII Wrap-Up in November
  October 11, 2021

• Takeda’s CMV Drug Maribavir Earns FDA AdCom Backing
  October 11, 2021

• Licensing Izcargo to Takeda First Step to Expanded Application of JCR’s BBB-Penetrating Technology: Chairman
  October 8, 2021

• Kyowa Kirin Calls Off Entinostat Breast Cancer Program in Japan
  October 8, 2021

• Japan Ethical Drug Sales Zoom 8.8% in August: Crecon
  October 8, 2021

• Otsuka Gets EU Nod for Pediatric Formulation of TB Drug Deltyba
  October 7, 2021

• Opdivo Top-Selling Drug in Japan in September: Encise
  October 7, 2021

• Takeda Suspends PII Trials of Narcolepsy Drug Hopeful on Safety Concerns
  October 7, 2021

• Asahi Kasei Aims for Pharma Sales of 150 Billion Yen by FY2025
  October 6, 2021

• Oncolys Aims to Bring Nucleocapsid Inhibitor into Clinic Next Year for COVID-19 Treatment
  October 6, 2021

• JCR’s Hurler Syndrome Drug Earns Fast-Track Status in US
  October 6, 2021

• Streamline Regulatory Approval Process with Overseas Data: Rakuten Chief
  October 5, 2021

• Astellas to Accelerate Drug Discovery by Forming Specialized Small Teams by Modality: CScO
  October 5, 2021

• Enhertu Gets Breakthrough Therapy Tag for 2nd Line Breast Cancer
  October 5, 2021

• Ferring Rolls Out Ovulation Inducer Rekovelle in Japan
  October 5, 2021

• “Human Error” Is to Blame for Contamination of Moderna COVID-19 Vaccines: Report
  October 4, 2021

• Sumitomo Dainippon, Otsuka Ink Global Collaboration for 4 Neuropsychiatric Drugs
  October 1, 2021

• JCR Hooks Up with Takeda on Global Expansion of Hunter Syndrome Drug
  October 1, 2021

• Asahi Kasei Files Antifungal Cresemba in Japan
  October 1, 2021

• Santen, Singapore National Eye Centre Team Up on Training Program for Eye Care Providers
  October 1, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 211
• 212
• 213
• 214
• 215
• 216
• 217
• 218
• 219
• …
• Next ›
• 最終 »